Global Diabetes Compact

Global Diabetes Compact
Name	Global Diabetes Compact
Formation	2021
Founder	World Health Organization
Type	Initiative
Headquarters	Geneva

Global Diabetes Compact is a multilateral initiative launched to accelerate action against diabetes by coordinating policy, service delivery, research, and financing. It was convened by World Health Organization leadership with contributions from United Nations, World Bank, Bill & Melinda Gates Foundation, and civil society to align national strategies, improve access to diagnostics and medicines, and mobilize partners. The Compact seeks to translate commitments from forums such as the UN General Assembly and the Global Fund into operational programs at country level.

Background and Rationale

The Compact emerged from rising epidemiological trends documented by International Diabetes Federation, Institute for Health Metrics and Evaluation, and WHO Global Health Observatory showing increasing prevalence in regions highlighted by Pan American Health Organization, Africa CDC, and European Centre for Disease Prevention and Control. Key antecedents include the WHO Global NCD Action Plan 2013–2020, the Sustainable Development Goals adopted at the United Nations General Assembly, and policy recommendations from World Economic Forum health task forces. Influential reports from Lancet Commission on Diabetes and analyses by World Bank Group underscored economic burdens akin to financial assessments in IMF studies, prompting calls from leaders such as Tedros Adhanom Ghebreyesus and advocates linked to International Diabetes Federation to create a coordinated mechanism.

Objectives and Pillars

The Compact is organized around strategic aims similar to pillars used by WHO, UNICEF, and UNAIDS. Objectives include scaling access to insulin and glucose monitoring as prioritized in documents by Essential Medicines List Committee and improving primary care capacity referenced by Universal Health Coverage frameworks from World Health Organization and World Bank. Core pillars mirror stewardship models from Global Fund and Gavi, the Vaccine Alliance: prevention aligned with guidance from Centers for Disease Control and Prevention and Public Health England; diagnosis and treatment following standards from American Diabetes Association and International Diabetes Federation; and research and innovation inspired by partnerships with National Institutes of Health and European Commission research programs.

Governance and Partners

Governance structures draw on precedents set by Global Fund and Gavi with a steering group including World Health Organization, United Nations Development Programme, World Bank, and philanthropic funders such as Bill & Melinda Gates Foundation and Rockefeller Foundation. Civil society representation echoes models used by Médecins Sans Frontières and International Diabetes Federation member associations, while private sector engagement follows frameworks negotiated with companies like Novo Nordisk, Sanofi, and device manufacturers modeled after procurement arrangements with UNICEF Supply Division. Academic partners include Harvard T.H. Chan School of Public Health, London School of Hygiene & Tropical Medicine, and Karolinska Institutet.

Initiatives and Programs

Programs combine policy, procurement, and service delivery interventions inspired by initiatives like Access to Medicine Index and P4H (Primary Health Care) Partnership. Examples include pooled procurement pilots akin to mechanisms used by PAHO Strategic Fund, national insulin access programs modeled after Bangladesh Health Sector Program, and digital health pilots drawing on WHO mHealth recommendations and platforms developed by PATH and Clinton Health Access Initiative. Prevention campaigns leverage alliances with World Heart Federation and Global Action Plan for the Prevention and Control of NCDs while capacity-building initiatives collaborate with Royal Society of Medicine and regional training centers such as African Centres for Disease Control and Prevention academy efforts.

Implementation and Funding

Implementation pathways utilize country engagement modalities similar to those employed by UN Country Teams and the Global Financing Facility. Funding streams combine multilateral financing from World Bank, concessional loans coordinated with International Finance Corporation, philanthropic grants from Wellcome Trust and Bill & Melinda Gates Foundation, and voluntary contributions aggregated through mechanisms reminiscent of Global Fund replenishment processes. Procurement financing references pooled-buying examples from PAHO and negotiations informed by legal frameworks used by WTO agreements on trade and health. Technical assistance is delivered through partnerships with WHO Regional Offices, UNICEF, and academic consortia.

Impact, Monitoring, and Evaluation

Monitoring frameworks align with indicators from Sustainable Development Goals and reporting conventions employed by WHO Global NCD Platform and UN health statistics. Evaluation uses methods developed by OECD and impact assessment techniques from Institute for Health Metrics and Evaluation and Cochrane Collaboration systematic review standards. Data partnerships draw on surveillance systems like Demographic and Health Surveys and laboratory networks coordinated by European Centre for Disease Prevention and Control and Africa CDC. Results are intended to inform policy cycles at forums such as the World Health Assembly and the UN High-level Meeting on NCDs.

Criticisms and Challenges

Critiques have paralleled debates around Gavi and Global Fund regarding sustainability, governance transparency, and private sector influence involving corporations like Novo Nordisk and Sanofi. Implementation barriers resemble issues documented in WHO NCD cost-effectiveness studies and country case studies from World Bank analyses: supply chain fragility, intellectual property constraints referenced in TRIPS Agreement discussions, and inequities highlighted by Human Rights Watch and Amnesty International reports. Evaluation challenges mirror those faced by UNAIDS and Global Polio Eradication Initiative in attributing outcomes across overlapping programs and measuring long-term economic impacts assessed by International Monetary Fund and OECD studies.

Category:Public health initiatives